Contract Testing Services

At Setolabo, in collaboration with our partner MEDBANK PTE, Ltd., we provide a wide range of contract testing services, including next-generation sequencing (NGS), blood tests, and immunological assays.

Test Menu

Next-Generation Sequencing (NGS)

Immunological Tests

AVITI LTAVITI (Element Biosciences)– operated at MEDBANK Sequencing Center

MiSeq (Illumina)

LUMIPULSE L2400 (Fujirebio Inc.)

Other Blood Tests

 

Next-Generation Sequencing (NGS)

We offer contract analysis services using the latest next-generation sequencers.
Depending on your research objectives and project scale, the optimal sequencing platform can be selected.

 

 

AVITI

AVITI LT

The AVITI sequencer delivers high accuracy and cost efficiency.

・Achieves Q40 or higher in over 90% of bases (≤1 error per 10,000 bases)
・Provides highly reliable data suitable for research use.

AVITI supports a broad range of applications, including:

・Whole-exome sequencing (WES)
・RNA-Seq
・Small RNA analysis (including miRNA)
・DNA methylation analysis
・Targeted resequencing (panel sequencing)

AVITI is also being utilized in our joint clinical research project with Kagawa University, which has been adopted under the FY2024 “Hiroshima Unicorn 10” Asia Co-Creation Program conducted by Hiroshima Prefecture. Its reliability in real-world research settings has been demonstrated, ensuring that it can be used with confidence.

👉 Learn more about AVITI

MiSeq

We have implemented Illumina’s next-generation sequencer, the MiSeq. The MiSeq is the only desktop NGS platform capable of generating up to 15 Gb of data per run with 2 × 300 bp paired-end reads. This enables small-genome assembly and, in particular, the detection of target variants in homopolymer regions with unparalleled accuracy.

Next-generation sequencing (NGS) is a powerful foundational technology that can determine the sequences of thousands to millions of DNA molecules simultaneously. Its high-throughput, rapid processing—such as sequencing multiple samples at once—has revolutionized fields like personalized medicine, hereditary disease research, and clinical diagnostics.

 

Immunological Testing

At the Setolabo Hygiene Testing Laboratory in Osaka, we have installed and operate the LumiPulse L2400—a system ordinarily found only in university and large hospitals. The LumiPulse is a fully automated chemiluminescent enzyme immunoassay system that uses the chemiluminescent substrate AMPPD and ferrite‐particle solid‐phase reagents, delivering high sensitivity, rapid processing, and easy operation. Not only does it offer the highest throughput in the LumiPulse series at 240 tests per hour, but it also features external sampling capability and extensive expandability for integration with conveyor‐line systems.

◯ Possible inspection items

hepatitis infectious disease tumor marker thyroid disease sex hormones cardiovascular disease
HBsAg-HQ SARS-CoV-2 Ag CEA TSH LH BNP
HBsAb SARS-CoV-2 IgM * AFP FT3 FSH High sensitivity TnI
 

HBcAb

SARS-CoV-2 S-IgG * CA19-9 FT4 PRL Myoglobin
HBcIgM SARS-CoV-2 N-IgG * CA125 T3 E2(estradiol) CK-MB
iTACT HBcrAg Flu-A&B CA15-3 T4 progesterone β2-m
HBeAg HTLV-Ⅰ/Ⅱ PSA TgAb testosterone L-FABP
HBeAb HIV Ag/Ab Shifra TPOAb βHCG
HCVAb TP SCC TRAb
Type IV collagen・7S PCT ProGRP iTACT Tg
IL-2R
PepsinogenI
PepsinogenⅡ
PIVKA-Ⅱ 1)
TDM Bone related Pituitary gland Adrenal hormones lifestyle-related diseases others
iTACT Tacrolimus whole-PTH 2) aldosterone insulin IgE IL-6
Methotrexate Lenin C-peptide ferritin PGE-MUM
High molecular weight adiponectin * KL-6 1)

COVID-19 Testing

At the Setolabo Hygiene Testing Laboratory, we offer COVID-19 antigen tests, antibody tests, and PCR tests. For PCR, we have deployed Takara Bio’s latest real-time PCR instrument (CronoSTAR™ 96 Real-Time PCR System (6-channel)), released in August 2020. We use the Ministry of Health, Labour and Welfare–approved Takara Bio PCR assay kits (SARS-CoV-2 Direct Detection RT-qPCR Kit Ver.1/Ver.2), enabling tests to be covered by public health insurance.

Moreover, all analyses are performed exclusively by physicians, clinical laboratory technicians, and researchers with hands-on experience in clinical diagnostics and research. Although PCR testing is legally permissible for non-professionals, we do not allow inexperienced staff or laypersons to conduct any of our laboratory tests.

Facilities

  • Setolabo Clinical Laboratory (Ikuno-ku, Osaka City – registered with Osaka City Public Health Center)

  • Setolabo Research Institute Kagawa (Mure-cho, Takamatsu City)

  • MEDBANK Sequencing Center (AVITI installation and operation site)

All facilities are operated under official authorization from public health centers and established partnership agreements.


Contact

For inquiries about contract testing services, please contact us at:
📧 aviti@setolabo.jp

最近の記事
おすすめ記事
  1. COVID-19 “false positives/false negatives” and quality control

  2. BLOG

  1. 登録されている記事はございません。
TOP